{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:11:28Z","timestamp":1793902288635,"version":"4.8.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.clinthera.2024.09.006","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T17:03:13Z","timestamp":1728406993000},"page":"1034-1040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evaluation of Dexmedetomidine Withdrawal and Management After Prolonged Infusion"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8762-4291","authenticated-orcid":false,"given":"Christine S.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin E.","family":"Crowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2024.09.006_bib0001","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","article-title":"Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU","volume":"46","author":"Devlin","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0002","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s40265-015-0419-5","article-title":"Dexmedetomidine: a review of its use for sedation in the intensive care setting","volume":"75","author":"Keating","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0003","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/22201173.2010.10872648","article-title":"Dexmedetomidine in sedation","volume":"16","author":"Kruger","year":"2010","journal-title":"South Afr J Anaesth Analg"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0004","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/cc712","article-title":"Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care","volume":"4","author":"Venn","year":"2000","journal-title":"Crit Care"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0005","unstructured":"Dexmedetomidine [package insert]. Lake Forest, IL: Hospira, Inc; 2013."},{"key":"10.1016\/j.clinthera.2024.09.006_bib0006","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jcrc.2020.10.024","article-title":"Evaluation of dexmedetomidine withdrawal in critically ill adults","volume":"62","author":"Pathan","year":"2021","journal-title":"J Crit Care"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0007","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00134-011-2441-8","article-title":"Discontinuation of prolonged infusions of dexmedetomidine in critically ill children with heart disease","volume":"38","author":"Burbano","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0008","first-page":"453","article-title":"Prolonged dexmedetomidine infusion and drug withdrawal in critically ill children","volume":"22","author":"Haenecour","year":"2017","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0009","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/0960327112454896","article-title":"Two cases of acute dexmedetomidine withdrawal syndrome following prolonged infusion in the intensive care unit: report of cases and review of the literature","volume":"32","author":"Kukoyi","year":"2013","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0010","first-page":"278","article-title":"The impact of a clonidine transition protocol on dexmedetomidine withdrawal in critically ill pediatric patients","volume":"25","author":"Liu","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0011","first-page":"104","article-title":"Evaluating the transition from dexmedetomidine to clonidine for the prevention of withdrawal in critically ill pediatric patients","volume":"25","author":"Lee","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0012","doi-asserted-by":"crossref","DOI":"10.1177\/2050312115621767","article-title":"Evaluating the transition from dexmedetomidine to clonidine for agitation management in the intensive care unit","volume":"3","author":"Terry","year":"2015","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0013","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/PCC.0b013e31818c8328","article-title":"The withdrawal assessment tool-1 (WAT-1): an assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients","volume":"9","author":"Franck","year":"2008","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0014","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1007\/s00134-004-2417-z","article-title":"Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects","volume":"30","author":"Shehabi","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jcrc.2020.06.006","article-title":"Identification of risk factors for hypertension and tachycardia upon dexmedetomidine discontinuation","volume":"59","author":"Salah","year":"2020","journal-title":"J Crit Care"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0016","doi-asserted-by":"crossref","first-page":"e0035","DOI":"10.1097\/CCE.0000000000000035","article-title":"Incidence of dexmedetomidine withdrawal in adult critically ill patients: a pilot study","volume":"1","author":"Bouajram","year":"2019","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0017","doi-asserted-by":"crossref","first-page":"304","DOI":"10.21037\/atm.2018.07.08","article-title":"Prolonged dexmedetomidine infusion in critically ill adult patients: a retrospective analysis of a large clinical database Multiparameter Intelligent Monitoring in Intensive Care III","volume":"6","author":"Zhao","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0018","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1164\/rccm.2107138","article-title":"The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients","volume":"166","author":"Sessler","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0019","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1001\/jama.286.21.2703","article-title":"Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU)","volume":"286","author":"Ely","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0020","unstructured":"Dana-Farber Cancer Institute\/Brigham, Women\u2019s Hospital. Pain Management Tables and Guidelines. 2024. https:\/\/pinkbook.dfci.org\/assets\/docs\/pinkBook24.pdf. Accessed September 25, 2024."},{"key":"10.1016\/j.clinthera.2024.09.006_bib0021","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention. CDC Clinical Practice Guideline for Prescribing Opioids for Pain \u2014 United States, 2022. https:\/\/www.cdc.gov\/mmwr\/volumes\/71\/rr\/rr7103a1.htm#T1_down. Accessed September 25, 2024.","DOI":"10.15585\/mmwr.rr7103a1"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0022","unstructured":"ClinCalc. Equivalent benzodiazepine calculator. https:\/\/clincalc.com\/Benzodiazepine. Accessed September 25, 2024."},{"key":"10.1016\/j.clinthera.2024.09.006_bib0023","first-page":"45","article-title":"Effects of clonidine on withdrawal from long-term dexmedetomidine in the pediatric patient","volume":"20","author":"Lardieri","year":"2015","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0024","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00540-013-1678-5","article-title":"Safety and efficacy of dexmedetomidine for long-term sedation in critically ill patients","volume":"28","author":"Ozaki","year":"2014","journal-title":"J Anesth"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0025","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/phar.2323","article-title":"Incidence of rebound hypertension after discontinuation of dexmedetomidine","volume":"39","author":"Flieller","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0026","first-page":"21","article-title":"Safety and effectiveness of dexmedetomidine in the pediatric intensive care unit (SAD-PICU)","volume":"66","author":"Carney","year":"2013","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0027","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1460-9592.2007.02377.x","article-title":"Acute discontinuation syndrome from dexmedetomidine after protracted use in a pediatric patient","volume":"18","author":"Weber","year":"2008","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0028","first-page":"38","article-title":"Neurologic withdrawal symptoms following abrupt discontinuation of a prolonged dexmedetomidine infusion in a child","volume":"15","author":"Miller","year":"2010","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2024.09.006_bib0029","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/phar.1559","article-title":"Transition from dexmedetomidine to enteral clonidine for ICU sedation: an observational pilot study","volume":"35","author":"Gagnon","year":"2015","journal-title":"Pharmacotherapy"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291824002686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291824002686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T20:00:21Z","timestamp":1733860821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291824002686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0149291824002686"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2024.09.006","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Dexmedetomidine Withdrawal and Management After Prolonged Infusion","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2024.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}